π
|
Incidence of nephrogenic systemic fibrosis at two large medical centers.
10 auth.
M. Prince,
Honglei Zhang,
Michael Morris,
J. Macgregor,
M. Grossman,
J. Silberzweig,
...
R. DeLaPaz,
Henry J. Lee,
C. Magro,
A. Valeri
|
8 |
2008 |
8 π
|
π’
|
Mitigating Risk of COVID-19 in Dialysis Facilities.
A. Kliger,
J. Silberzweig
|
7 |
2020 |
7 π’
|
π
|
The Effects of Sevelamer and Calcium Acetate on Proxies of Atherosclerotic and Arteriosclerotic Vascular Disease in Hemodialysis Patients
10 auth.
G. Chertow,
P. Raggi,
J. McCarthy,
G. Schulman,
J. Silberzweig,
A. Kuhlik,
...
W. Goodman,
A. Boulay,
S. Burke,
R. Toto
|
6 |
2003 |
6 π
|
π
|
Sorbents in Acute Renal Failure and End-Stage Renal Disease: Middle Molecule and Cytokine Removal
10 auth.
J. Winchester,
J. Silberzweig,
C. Ronco,
V. Kuntsevich,
D. Levine,
T. Parker,
...
J. Kellum,
J. Salsberg,
P. Quartararo,
N. Levin
|
5 |
2004 |
5 π
|
π
|
Characteristics of Acute Kidney Injury in Hospitalized COVID-19 Patients in an Urban Academic Medical Center.
27 auth.
J. Lee,
J. Silberzweig,
Oleh M. Akchurin,
Mary E. Choi,
Vesh Srivatana,
Jonathan T. Lin,
Frank Liu,
Line P Malha,
M. Lubetzky,
D. Dadhania,
D. Shankaranarayanan,
Daniil Shimonov,
S. Neupane,
T. Salinas,
Aarti Bhasin,
...
E. Varma,
Lorenz Leuprecht,
Supriya Gerardine,
P. Lamba,
P. Goyal,
Eric Caliendo,
V. Tiase,
R. Sharma,
Joel C Park,
P. Steel,
M. Suthanthiran,
Yiye Zhang
|
4 |
2020 |
4 π
|
π
|
Prevalence, persistence, and microbiology of Staphylococcus aureus nasal carriage among hemodialysis outpatients at a major New York Hospital.
12 auth.
Elizabeth L. Alexander,
D. Morgan,
S. Kesh,
S. Weisenberg,
J. M. Zaleskas,
A. Kaltsas,
...
J. Chevalier,
J. Silberzweig,
Y. BarrΓ³n,
J. Mediavilla,
B. Kreiswirth,
K. Rhee
|
4 |
2011 |
4 π
|
π¦
|
Removal of gadolinium by dialysis: Review of different strategies and techniques
J. Silberzweig,
Miriam Chung
|
4 |
2009 |
4 π¦
|
π’
|
COVID-19 and Dialysis Patients: Unsolved Problems in Early 2021
A. Kliger,
J. Silberzweig
|
3 |
2021 |
3 π’
|
π¦
|
Rationing Scarce Resources: The Potential Impact of COVID-19 on Patients with Chronic Kidney Disease.
J. Silberzweig,
T. Ikizler,
H. Kramer,
P. Palevsky,
J. Vassalotti,
A. Kliger
|
3 |
2020 |
3 π¦
|